SwabExpress:免核酸提取的新冠病毒检测端到端流程
该研究开发了SwabExpress流程,使用前鼻拭子干燥转运并在低TE缓冲液中洗脱,跳过转运培养基和核酸提取,直接进行RT-qPCR。经热灭活和蛋白酶K消化优化后,与提取法RT-qPCR平行比较,检测限为2-4分子/µL,灵敏度100%,特异性99.4%;在真实样本中性能优于自动化提取系统,同时降低成本与手工时间。
要点
- 免提取直接RT-qPCR,检测限2-4分子/µL
- 与提取法RT-qPCR平行比较,灵敏度100%、特异性99.4%
- 真实样本中性能优于自动化提取系统,且降低成本与手工时间
核心结论
- SwabExpress简化流程可在不牺牲检测性能的前提下支持新冠检测规模化。
- 该流程可作为简化PCR类临床实验室检测的模板,尤其适用于大流行期间关键物资短缺时。
研究设计与样本
- 开发并评估前鼻拭子干燥转运、低TE缓冲液洗脱、直接RT-qPCR的端到端流程。
- 采用热灭活并加入蛋白酶K消化以减少扩增干扰。
- 在存档和前瞻性收集的拭子标本中验证并优化性能。
主要发现
- 优化后检测限为2-4分子/µL。
- 与提取法RT-qPCR平行比较,灵敏度100%、特异性99.4%。
- 真实样本中SwabExpress性能优于自动化提取系统,同时降低成本和手工时间。
关键数值与推荐
- 检测限2-4分子/µL。
- 灵敏度100%、特异性99.4%(与提取法RT-qPCR平行比较)。
临床怎么用
- 可使用前鼻拭子干燥转运、低TE缓冲液洗脱后直接RT-qPCR,免去转运培养基和核酸提取。
- 热灭活联合蛋白酶K消化可降低扩增干扰。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The urgent need for massively scaled clinical testing for SARS-CoV-2, along with global shortages of critical reagents and supplies, has necessitated development of streamlined laboratory testing protocols. Conventional nucleic acid testing for SARS-CoV-2 involves collection of a clinical specimen with a nasopharyngeal swab in transport medium, nucleic acid extraction, and quantitative reverse-transcription PCR (RT-qPCR). As testing has scaled across the world, the global supply chain has buckled, rendering testing reagents and materials scarce. To address shortages, we developed SwabExpress, an end-to-end protocol developed to employ mass produced anterior nares swabs and bypass the requirement for transport media and nucleic acid extraction. METHODS: We evaluated anterior nares swabs, transported dry and eluted in low-TE buffer as a direct-to-RT-qPCR alternative to extraction-dependent viral transport media. We validated our protocol of using heat treatment for viral inactivation and added a proteinase K digestion step to reduce amplification interference. We tested this protocol across archived and prospectively collected swab specimens to fine-tune test performance. RESULTS: After optimization, SwabExpress has a low limit of detection at 2-4 molecules/µL, 100% sensitivity, and 99.4% specificity when compared side by side with a traditional RT-qPCR protocol employing extraction. On real-world specimens, SwabExpress outperforms an automated extraction system while simultaneously reducing cost and hands-on time. CONCLUSION: SwabExpress is a simplified workflow that facilitates scaled testing for COVID-19 without sacrificing test performance. It may serve as a template for the simplification of PCR-based clinical laboratory tests, particularly in times of critical shortages during pandemics.
引用
- Srivatsan S, Heidl S, Pfau B, et al. SwabExpress: An End-to-End Protocol for Extraction-Free COVID-19 Testing. Clin Chem. 2021. PMID: 34286830. doi:10.1093/clinchem/hvab132
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。